Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-02 06:02 am Unchanged | 13G | TOTTENHAM ACQUISITION I LTDUNI TOTAU | UNITED THERAPEUTICS Corp UTHR | 2,869,517 3.89% | 0 (Unchanged) | View |
| 2023-01-24 1:56 pm Purchase | 13G | UNITED THERAPEUTICS CORP UTHR | BlackRock Inc. BLK | 4,510,211 9.9% | 271,036 (+6.39%) | View |
| 2023-01-17 06:02 am Sale | 13G | TOTTENHAM ACQUISITION I LTDUNI TOTAU | UNITED THERAPEUTICS Corp UTHR | 2,869,517 3.89% | -786,575 (-21.51%) | View |
| 2022-02-11 3:50 pm Sale | 13G | UNITED THERAPEUTICS CORP UTHR | RENAISSANCE TECHNOLOGIES LLC | 2,917,191 6.48% | -690,100 (-19.13%) | View |
| 2022-02-11 10:02 am Purchase | 13G | UNITED THERAPEUTICS CORP UTHR | Avoro Capital Advisors LLC | 3,035,000 6.7% | 185,000 (+6.49%) | View |
| 2022-02-10 08:42 am Purchase | 13G | UNITED THERAPEUTICS CORP UTHR | VANGUARD GROUP INC | 4,160,963 9.24% | 196,962 (+4.97%) | View |
| 2022-02-09 10:01 am Purchase | 13G | UNITED THERAPEUTICS CORP UTHR | FMR LLC | 2,523,378 5.602% | 200,695 (+8.64%) | View |
| 2022-02-04 4:31 pm Purchase | 13G | CELULARITY INC CELU | UNITED THERAPEUTICS Corp UTHR | 7,968,848 6.51% | 7,968,848 (New Position) | View |
| 2022-02-04 4:31 pm Purchase | 13G | UNITED THERAPEUTICS CORP UTHR | ROTHBLATT MARTINE A | 4,118,487 8.5% | 489,001 (+13.47%) | View |
| 2022-02-02 7:11 pm Sale | 13G | UNITED THERAPEUTICS CORP UTHR | BlackRock Inc. BLK | 4,239,175 9.4% | -33,949 (-0.79%) | View |
| 2022-01-14 4:30 pm Sale | 13G | TOTTENHAM ACQUISITION I LTDUNI TOTAU | UNITED THERAPEUTICS Corp UTHR | 3,656,092 5.88% | -512,722 (-12.30%) | View |
| 2021-03-01 4:30 pm Purchase | 13G | UNITED THERAPEUTICS CORP UTHR | ROTHBLATT MARTINE A | 3,629,486 7.6% | 3,629,486 (New Position) | View |
| 2021-02-12 08:08 am Purchase | 13G | UNITED THERAPEUTICS CORP UTHR | Avoro Capital Advisors LLC | 2,850,000 6.4% | 2,850,000 (New Position) | View |
| 2021-02-11 2:18 pm Purchase | 13G | UNITED THERAPEUTICS CORP UTHR | RENAISSANCE TECHNOLOGIES LLC | 3,607,291 8.12% | 62,858 (+1.77%) | View |
| 2021-02-10 11:57 am Sale | 13G | UNITED THERAPEUTICS CORP UTHR | VANGUARD GROUP INC | 3,964,001 8.92% | -88,046 (-2.17%) | View |
| 2021-02-08 10:35 am Sale | 13G | UNITED THERAPEUTICS CORP UTHR | FMR LLC | 2,322,683 5.226% | -60,866 (-2.55%) | View |
| 2021-02-05 06:04 am Sale | 13G | TRANSMEDICS GROUP INC TMDX | UNITED THERAPEUTICS Corp UTHR | 0 0% | -1,458,413 (Position Closed) | View |
| 2021-02-01 08:23 am Sale | 13G | UNITED THERAPEUTICS CORP UTHR | BlackRock Inc. BLK | 4,273,124 9.6% | -367,961 (-7.93%) | View |
| 2021-01-08 4:30 pm Purchase | 13G | TOTTENHAM ACQUISITION I LTDUNI TOTAU | UNITED THERAPEUTICS Corp UTHR | 4,168,814 7% | 4,168,814 (New Position) | View |
| 2020-02-14 2:46 pm Sale | 13G | UNITED THERAPEUTICS CORP UTHR | AQR CAPITAL MANAGEMENT LLC | 671,129 1.53% | -1,843,434 (-73.31%) | View |